search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Effect of synbiotics in infants with atopic dermatitis up to 7 years of life.


- candidate number8451
- NTR NumberNTR2523
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR15-sep-2010
- Secondary IDsSYN.2.C/A Danone Research
- Public TitleEffect of synbiotics in infants with atopic dermatitis up to 7 years of life.
- Scientific TitleEffect of synbiotics in infants with atopic dermatitis up to 7 years of life.
- ACRONYMSYNBAD Follow Up Study
- hypothesisA positive effect of the study product in preventing asthma like symptoms in infants at high risk for developing asthma later in childhood.
- Healt Condition(s) or Problem(s) studiedAllergy, Asthma
- Inclusion criteria1. Participation and completion of Synbad study (all PP subjects);
2. Between 5 years and 6 months and 6 years of age;
3. Written informed consent from parents/caregivers/legal representatives.
- Exclusion criteriaInvestigator's uncertainty about the willingness or ability of the family to comply with the protocol requirements.
- mec approval receivedyes
- multicenter trialno
- randomisedno
- groupParallel
- Type2 or more arms, non-randomized
- Studytypeobservational
- planned startdate 25-sep-2010
- planned closingdate31-dec-2013
- Target number of participants78
- InterventionsNot applicable. This is an observational follow up study that investigates interventions that were done in a previous study.
- Primary outcomePrevalence of asthma, measured by a lungtest & questionnaires.
- Secondary outcomeAllergic manifestations, as diagnosed by a physician or by means of questionnaires
- TimepointsThe study will last 58 weeks and consists of 4 hospital visits and 3 phone calls.
- Trial web site
- statusinclusion stopped: follow-up
- CONTACT FOR PUBLIC QUERIESDr. M. Roelofs
- CONTACT for SCIENTIFIC QUERIESDr. M. Roelofs
- Sponsor/Initiator Danone Research B.V.
- Funding
(Source(s) of Monetary or Material Support)
Nutricia Research - Centre for Specialised Nutrition
- PublicationsN/A
- Brief summarySince atopic dermatitis (AD) is often the starting point of the "allergic march" and children with AD have a 40% chance of developing asthma, it is interesting to explore if certain probiotic strains can bring the allergic march to a halt,and prevent the development of asthma in these children.

The original Synbad Study showed that the infants with AD who received synbiotics have a lower prevalence of asthma-like symptoms and asthma medication use at one-year follow-up than those who received placebo (van der Aa, Allergy 2010 accepted for publication).

Since this study showed a positive effect in preventing asthma like symptoms in infants at high risk for developing asthma later in childhood, this follow-up study is a good opportunity for further exploration of the prevalence of established asthma in the Synbad children up to 7 years of age.

This study is an observational study in which the same groups will be analysed as in the original double blind parallel randomised SYNBAD trial. For the participants, the study will last 58 weeks and consists of 4 hospital visits and 3 phone calls.
- Main changes (audit trail)31-03-2014: The first subject was included 24Mar2011 and the last subject was out of the study 8Oct2013. Danone Research changed names into Nutricia Research - AB
- RECORD15-sep-2010 - 31-mrt-2014


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl